A perspective on surrogate endpoints in controlled clinical trials
From MaRDI portal
Publication:5424596
DOI10.1191/0962280204sm362razbMath1121.62639OpenAlexW2340418739WikidataQ35805910 ScholiaQ35805910MaRDI QIDQ5424596
Ariel Alonso, Marc Buyse, Tomasz Burzykowski, Geert Molenberghs
Publication date: 5 November 2007
Published in: Statistical Methods in Medical Research (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/1942/673
Related Items
Center-within-trial versus trial-level evaluation of surrogate endpoints ⋮ Dynamic optimal strategy for monitoring disease recurrence ⋮ Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
